Expression of a variant of CD28 on a subpopulation of human NK cells: Implications for B7-mediated stimulation of NK cells

Journal of Immunology

Volumn 163, Issue 1, 1999, Pages 62-70

  Galea Lauri, Joanna ^a   Darling, David ^a   Gan, Shu Uin ^a,b   Krivochtchapov, Leonid ^a,c   Kuiper, Marcel ^a   Gäken, Joop ^a   Souberbielle, Bernard ^a,d   Farzaneh, Farzin ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^c I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

^d ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD69 ANTIGEN; HLA ANTIGEN CLASS 2; INTERLEUKIN 2 RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY;

ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; CELL STIMULATION; CYTOLYSIS; CYTOTOXICITY; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ADULT; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; B-LYMPHOCYTES; BINDING SITES, ANTIBODY; CELL SEPARATION; CELLS, CULTURED; CLONE CELLS; COCULTURE TECHNIQUES; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA ANTIGENS; HUMANS; K562 CELLS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MICE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-2; RNA, MESSENGER; SARCOMA, EXPERIMENTAL; SPECIES SPECIFICITY; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0033169022     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Yokoyama, W. 1998. Natural killer cell receptors. Curr. Opin. Immunol. 10:298.
2. Colonna, M. 1996. Natural killer cell receptor specific for MHC class 1 molecules. Curr. Opin. Immunol. 8:101.
3. Lanier, L. L., and J. H. Phillips. 1996. Inhibitory MHC class I receptors on NK cells and T cells. Immunol. Today 17:86.
4. Chambers, W. H., and C. S. Brissette-Storkus. 1995. Hanging in the balance: natural killer cell recognition of target cells. Chem. Biol. 2:429.
5. Leibson, P. J. 1995. Viewpoint: signal transduction during natural killer cell activation. Nat. Immun. 14:117.
6. Lanier, L. L., G. Yu, and J. H. Phillips. 1989. Co-association of CD3ζ with a receptor (CD16) for IgG Fc on human natural killer cells. Nature 342:803.
7. + human natural killer cells. Int. J. Cancer 44:727.
8. Yeh, K. Y., B. A. Pulaski, M. L. Woods, A. J. McAdam, A. A. Gaspari, J. G. Frelinger, and E. M. Lord. 1995. B7-1 enhances natural killer cell-mediated cytotoxicity and inhibits tumor growth of a poorly immunogenic murine carcinoma. Cell Immunol. 165:217.
9. Geldhof, A. B., G. Raes, M. Bakkus, S. Devos, K. Thielemans, and P. De Baetselier. 1995. Expression of B7-1 by highly metastatic mouse T lymphomas induces optimal natural killer cell-mediated cytotoxicity. Cancer Res. 55:2730.
10. Chambers, B. J., M. Salcedo, and H. Ljunggren. 1996. Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1). Immunity 5:311.
11. Nandi, D., J. A. Gross, and J. P. Allison. 1994. CD28-mediated costimulation is necessary for optimal proliferation of murine NK cells. J. Immunol. 152:3361.
12. Chen, L., P. McGowan, S. Ashe, J. Johnston, Y. Li, I. Hellstrom, and K. E. Hellstrom. 1994. Tumor immunogenicity determines the effect of B7 co-stimulation on T cell-mediated tumor immunity. J. Exp. Med. 179:523.
13. + mediated rejection of established tumors. Hum. Gene Ther. 8:477.
14. Nagler, A., L. L. Lanier, S. Cwirla, and J. H. Phillips. 1989. Comparative studies of human FcRIII-positive and negative natural killer cells. J. Immunol. 143:3183.
15. Azuma, M., M. Cayabyab, D. Buck, J. H. Phillips, and L. L. Lanier. 1992. Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line. J. Immunol. 149:1115.
16. Robertson, M. J., K. J. Cochran, C. Cameron, J. M. Le, R. Tantravahi, and J. Ritz. 1996. Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp. Hematol. 24:406.
17. Dessureault, S., and S. Gallinger. 1996. Allogeneic lymphocyte responses to B7-1 expressing human cancer lines. J. Surg. Res. 64:42.
18. Lang, S., N. Vujanovic, B. Wollenberg, and T. Whiteside. 1998. Absence of B7.1-CD28/CTLA-4-mediated costimulation in human NK cells. Eur. J. Immunol. 28:780.
19. Aruffo, A., and B. Seed. 1987. Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system. Proc. Natl. Acad. Sci. USA 84:8573.
20. Lee, K., C. Taylor, B. Petryniak, L. Turka, C. June, and C. Thompson. 1990. The genomic organization of the CD28 gene: implications for the regulation of CD28 mRNA expression and heterogeneity. J. Immunol. 145:344.
21. Gmunder, H., and W. Lesslauer. 1984. A 45-kDa human T-cell membrane glycoprotein functions in the regulation of cell proliferative responses. Eur. J. Biochem. 142:153.
22. Lesslauer, W., and H. Gmunder. 1986. Biochemical characterisation of the 9.3 antigens of human T cells: simultaneous expression of disulfide-bonded 90-kilo-dalton dimers and free subunits at the cell surface. Mol. Immunol. 23:271.
23. Traunecker, A., F. Oliveri, and K. Karjalainen. 1991. Myeloma based expression system for production of large mammalian proteins. Trends Biotechnol. 9:109.
24. Gäken, J., F. Farzaneh, C. Stocking, and W. Ostertag. 1992. Construction of a versatile set of retroviral vectors conferring hygromycin resistance. Biotechniques 13:32.
25. Hirst, W. J., A. Buggins, D. Darling, J. Gaken, F. Farzaneh, and G. J. Mufti. 1997. Enhanced immune costimulatory activity of primary acute myeloid leukaemia blasts after retrovirus-mediated gene transfer of B7.1. Gene Ther. 4:691.
26. Wilkinson, J., J. Galea-Lauri, R. Sellars, and C. Boniface. 1992. Identification and tissue distribution of rabbit leucocyte antigens recognised by monoclonal Abs. Immunology 76:625.
27. Bromelow, K., J. Galea-Lauri, M. O'Brien, and B. Souberbielle. 1998. A highly sensitive whole blood NK cell assay. J. Immunol. Methods 217:177.
28. Dohring, C., L. Angman, G. Spagnoli, and A. Lanzavecchia. 1994. T-helper-and accessory-cell-independent cytotoxic responses to human tumor cells transfected with a B7 retroviral vector. Int. J. Cancer 57:754.
29. Roger, R., J. Breard, M. Comisso, C. Bohuon, M. Pallardy, and J. Bertoglio. 1996. CD28-mediated cytotoxicity of YT natural killer cells on B7-positive targets induces rapid necrotic death independent of granule exocytosis. Cell Immunol. 168:24.
30. Hansen, J., P. Martin, and R. Nowinski. 1980. Monoclonal Abs identifying a novel T-cell antigen and Ia antigens of human lymphocytes. Immunogenetics 10:247.
31. Peach, R., J. Bajorath, W. Brady, G. Leytze, J. Greene, J. Naemura, and P. Linsley. 1994. Complementarity determining region 1 (CDR1)-and CDR3-analogous Regions in CTLA-4 and CD28 determine the binding to B7-1. J. Exp. Med. 180:2049.